Catalog

Acute Respiratory Distress Syndrome Cellular and Molecular Mechanisms and Clinical Management [electronic resource] :

  • Matalon, Sadis. editor. , Sznajder, Jacob Lasha. editor.
  • 1998
Acute Respiratory Distress Syndrome Cellular and Molecular Mechanisms and Clinical Management [electronic resource] :
  • Data Type
    Book
  • Title/Author
    Acute Respiratory Distress Syndrome[electronic resource] :Cellular and Molecular Mechanisms and Clinical Management / edited by Sadis Matalon, Jacob Lasha Sznajder.
  • Varying Title
    Proceedings of a NATO ASI held in Corfu, Greece, June 15-25, 1997
  • Author
    Matalon, Sadis., editor., Sznajder, Jacob Lasha., editor.
  • Authors
    SpringerLink (Online service)
  • Phy Desc.
    XV, 432 p. : online resource.
  • Total State.
    NATO ASI Series, Advanced Science Institutes Series ; 297
  • Contents Note
    SECTION 1: SODIUM (Na+) TRANSPORT AND FLUID CLEARANCE ACROSS THE NORMAL AND INJURED LUNGS -- Regulation of the Sodium Pump in Hyperoxic Lung Injury -- Lung Edema Clearance during Hyperoxic Lung Injury -- The Role of Lung Lymphatics in Pulmonary Edema Clearance -- Molecular Biology of Lung Na+ Absorption -- Regulation of Alveolar Sodium Transport by Hypoxia -- Vectorial Movement of Sodium in Lung Alveolar Epithelium: Role and Regulation of Na+,K-ATPase -- The Premature Infant?셲 Inability to Clear Fetal Lung Liquid Results in Respiratory Distress Syndrome (RDS) -- Role of Matrix Macromolecules in Controlling Lung Fluid Balance: Transition from a Dry Tissue to Edema** -- Role of the Na+-K+-ATPase ?2 Subunit in Lung Liquid Clearance** -- Aveolar Epithelial Fluid Transport under Normal and Pathological Conditions -- SECTION 2: ROLE OF THE PULMONARY SURFACTANT IN THE PATHOGENESIS AND TREATMENT OF ARDS -- Host Defense Capacities of Pulmonary Surfactant -- Alterations of Pulmonary Surfactant in ARDS?봒athogenic Role and Therapeutic Perspectives -- Surfactant Replacement in Patients with ARDS: Results of Clinical Trials -- Potential Role for Pulmonary Surfactant in Lung Transplantation -- Preparation of Surfactant and Lipid Vectors for Delivery of Proteins and Genes to Tissue -- Recombinant SP-C Based Surfactant Can Improve Lung Function in Saline Lavaged Sheep** -- SECTION 3: MECHANISMS AND MODIFICATION OF ACUTE AND CHRONIC LUNG INJURY -- Gene Therapy for the Acute Respiratory Distress Syndrome -- The Use of Recombinant Antioxidants in Neonatal Respiratory Distress Syndrome -- The Early Inflammatory Response in Acute Respiratory Distress Syndrome (ARDS) -- The N-Nitroso-N-Methylurethane Induced Acute Lung Injury Animal Model for ARDS: Minireview -- Hyperoxia Induced Fibrosis in ARDS and Bpd: Current Pathology and Cytokine Profiles -- MAP Kinases in Airway Disease: Standing at the Confluence of Basic and Clinical Science -- Oxidant-Regulated Gene Expression in Inflammatory Lung Disease -- Pulmonary Edema of Mixed or Incompletely Understood Pathogenesis -- Biologic Markers of Acute Lung Injury -- Pathways to Oxidative Cell Death -- Divergent Effects of Hypoxia and Oxidants on Mitochondrial Superoxide Dismutase (MnSOD) Gene Expression -- Cellular Sources of Cytokines in Pulmonary Fibrosis -- Strategies to Speed Lung Healing in ARDS -- Pulmonary Microvascular Occlusion in Aggregate Anaphylaxis** -- The Expression of ICAM-1 and P-Selectin Are Increased following Hemorrhage and Resuscitation in Mice** -- Increased Levels of Markers of Protein Oxidation in Bronchoalveolar Lavage Fluid from Patients with ARDS** -- SECTION 4: VENTILATORY STRATEGIES FOR THE MANAGEMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) -- The Use of PEEP in the Treatment of ARDS -- Tracheal Gas Insufflation -- Mechanical Ventilation in ARDS: Good or Bad News? -- Ventilator-Induced Lung Injury in Patients with ARDS -- Mechanical Ventilation for ARDS: Should We Reduce Tidal Volume? -- Endotracheal Tube Resistance and Passive Expiratory Time during Mechanical Ventilation in ARDS -- Use of Liquid Ventilation in Animal Models of ARDS -- Inhaled Prostacyclin for the Treatment of ARDS -- Is There Improvement in the Prognosis of ARDS? -- Effect of Ventilation Strategy on Cytokine Expression in an ex Vivo Lung Model** -- Abnormal Tissue Oxygenation and Cardiovascular Changes in Endotoxaemia: Beneficial Effects of Volume Resuscitation** -- SECTION 5: NITRIC OXIDE: FRIEND AND FOE -- Mechanisms of Nitric Oxide Induced Injury to the Alveolar Epithelium -- Macrophage Killing of Mycoplasmas: Involvement of Surfactant Protein A and Nitric Oxide -- Exhaled Nitric Oxide in Patients Undergoing Cardiothoracic Surgery: A New Diagnostic Tool? -- ARDS: Nitric Oxide as Cause and Therapy in Multiple Organ Failure (MOF) -- Role of Reactive Nitrogen Species in Asbestos-Induced Pleuro-Pulmonary Injury -- Biomarkers of Oxidative Stress in Adult Respiratory Distress Syndrome -- Reactive Oxygen and Nitrogen Species and Adult Respiratory Distress Syndrome (ARDS): New Mechanisms to Be Considered -- SECTION 6: HEALTH CARE LEGISLATION -- Health and Science Legislation in the United States.
  • Topical Term
    Medicine.
    Respiratory organs Diseases.
    Animal anatomy.
    Animal physiology.
    Medicine & Public Health.
    Pneumology/Respiratory System.
    Animal Physiology.
    Animal Anatomy / Morphology / Histology.
  • Host Item
    Springer eBooks
  • Additional Item
    Printed edition: 9780306458309
  • ISBN
    9781441986344
  • Language
    English